Research Institute for Complex Problems of Cardiovascular Diseases, Russia
13
3
3
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
23%
3 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Study on Efficacy, Safety and Durability of the UniLine Prosthesis in the Treatment of Aortic and Mitral Valve Disease
Role: collaborator
Post-market Clinical Monitoring of the Safety and Efficacy of the Aortic Valve Bioprothesis
Role: collaborator
The Study on the Use of "UniLine" Bioprosthesis in the Treatment of Isolated Aortic and Mitral Valve Diseases
Role: collaborator
Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.
Role: lead
Short-Term and Long-Term Cognitive Outcomes in Adults After Cardiac Surgery
Role: lead
Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions
Role: lead
Impact of the CareLink Express Remote Monitoring System on Early Detection of Atrial Fibrillation
Role: lead
Persistent Multiorgan Failure in Intensive Care Units
Role: lead
Electrostimulation of Skeletal Muscles in Patients Listed for a Heart Transplant
Role: lead
Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance
Role: lead
Myeloid-Derived Supressor Cells in Cardiac Surgery Patients
Role: lead
Dabigatran in Patients With Atrial Fibrillation and Mitral Biological Prostheses
Role: lead
Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation
Role: lead
All 13 trials loaded